News
Comorbid anxiety disorders compound challenges associated with bipolar disorder treatment.
A pair of phase 3 studies recently demonstrated that Teva Pharmaceutical Industries’ investigational treatment for moderate-to-severe asthma in patients with elevated blood eosinophils reduces asthma exacerbation rates by at least half.
Almost all women and seniors with atrial fibrillation should be receiving blood thinners, advises a new analysis of updated clinical practice guidelines.
Antibiotic prescribing rates tend to rise when retail clinics and physician offices compete for patients in affluent areas with abundant access to health care professionals.
Casting doubt on previous conjectures, a new study suggests that statins do not protect patients against Parkinson’s disease.
Teva Pharmaceutical Industries’ investigational drug designed to prevent chronic migraines recently demonstrated positive results in a phase 2 study.
An OTC allergy medication may be able to kill the bacteria behind Lyme disease, bringing researchers closer to developing the first targeted therapy for the debilitating infection.
Fed up with alleged unpaid overtime and missed rest periods, a Walmart pharmacist is fighting back against the retail giant with a class action suit.
Association News
Statement by Ralph G. Neas, President and CEO, GPhA, Regarding the Reintroduction of the FDA SOS Act
GPhA applauds the bipartisan reintroduction of the Food and Drug Administration Safety Over Sequestration Act.
Urging recognition of pharmacists as health care providers under Medicare Part B, NACDS cited that retail pharmacies are often the most readily accessible health care provider.
The National Community Pharmacists Association has written lawmakers to provide pharmacists’ feedback and recommendations to improve so-called "lock-in pharmacy” provisions within H.R. 1021.
The National Association of Chain Drug Stores expressed support for the Military Compensation and Retirement Modernization Commission's recognition of preserving pharmacy access and choice for TRICARE patients.
Biosimilars are poised to dramatically impact patient care in the United States.
AMCP CEO Edith A. Rosato, RPh, IOM, commented on the Centers for Medicare and Medicaid Services’ Advance Notice of Methodological Changes for Calendar Year 2016 for Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter.
ASHP will recognize the achievements of an accomplished group of health care practitioners with the organization’s 2015 Board of Directors’ Awards.
Bruce Josten, executive vice president for Government Affairs for the US Chamber of Commerce, will serve as the keynote speaker for the NACDS Political Action Committee breakfast during the 2015 NACDS Annual Meeting.
Pharmacy Market News
As of March 1, 2015, approximately 7,739,202 common shares of FMI (none of which were tendered by notice of guaranteed delivery) had been tendered and not withdrawn pursuant to the tender offer.
Cordis is a leader in the development and manufacture of interventional vascular technology with 2014 net revenues of approximately $780 million.
In support of International Rare Disease Day, the company is hosting several events internationally to help raise awareness of rare diseases as a critical global health issue requiring ongoing research, education and new treatments.
Strategic Alliance Partner News
Latest Issues
